
Laboratory Animal and Comparative Medicine ›› 2026, Vol. 46 ›› Issue (5): 629-639.DOI: 10.12300/j.issn.1674-5817.2025.212
• Laboratory Animals for Traditional Chinese Medicine Research • Previous Articles Next Articles
JIANG Miaomiao1,2, FANG Jinping2, HUANG Zongxuan2, LI Jiamin3, LIAO Huan1,2, ZHANG Wenqiang1,2, YU Jiaying2, YANG Yanyan4, LIAN Dawei1,2(
)(
)
Received:2025-12-17
Revised:2026-02-26
Online:2026-10-25
Published:2026-10-16
Correspondence to:
LIAN Dawei
CLC Number:
JIANG Miaomiao,FANG Jinping,HUANG Zongxuan,et al. Study on the Mechanism of Gegen Qinlian Decoction in Improving Diabetic Myocardial Injury[J]. Laboratory Animal and Comparative Medicine, 2026, 46(5): 629-639. DOI: 10.12300/j.issn.1674-5817.2025.212.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.slarc.org.cn/dwyx/EN/10.12300/j.issn.1674-5817.2025.212
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
| [1] |
LI J Y, PANDIAN V, DAVIDSON P M, et al. Burden and attributable risk factors of non-communicable diseases and subtypes in 204 countries and territories, 1990-2021: a systematic analysis for the global burden of disease study 2021[J]. Int J Surg, 2025, 111(3): 2385-2397. DOI: 10.1097/JS9. 0000000000002260.
|
| [2] |
XU Y, LU J L, LI M, et al. Diabetes in China part 1: epidemiology and risk factors[J]. Lancet Public Health, 2024, 9(12): e1089-e1097. DOI: 10.1016/S2468-2667(24)00250-0.
|
| [3] |
JIA W P, CHAN J C, WONG T Y, et al. Diabetes in China: epidemiology, pathophysiology and multi-omics[J]. Nat Metab, 2025, 7(1): 16-34. DOI: 10.1038/s42255-024-01190-w.
|
| [4] |
ZHANG N N, YU H, LIU T Z, et al. Bmal1 downregulation leads to diabetic cardiomyopathy by promoting Bcl2/IP3R-mediated mitochondrial Ca2+ overload[J]. Redox Biol, 2023, 64: 102788. DOI: 10.1016/j.redox.2023.102788.
|
| [5] |
ZHAO X D, LIU S W, WANG X, et al. Diabetic cardiomyopathy: Clinical phenotype and practice[J]. Front Endocrinol, 2022, 13: 1032268. DOI: 10.3389/fendo.2022.1032268.
|
| [6] |
CAI C, WU F, HE J, et al. Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies[J]. Int J Biol Sci, 2022, 18(14): 5276-5290. DOI: 10.7150/ijbs.75402.
|
| [7] |
李晓文. 基于PI3K/AKT信号通路探讨糖心平胶囊治疗糖尿病心肌病药效及机制[D]. 北京: 中国中医科学院, 2021. DOI: 10.27658/d.cnki.gzzyy.2021.000016.
|
|
LI X W. Efficacy and mechanism of Tangxinping capsule in treatment of diabetic cardiomyopathy based on PI3K/AKT signaling pathway[D]. Beijing: China Academy of Chinese Medical Sciences, 2021. DOI: 10.27658/d.cnki.gzzyy.2021.000016.
|
|
| [8] |
黄鑫磊, 贾雪雯, 丁元庆. 葛根芩连汤临床应用进展[J]. 山东中医药大学学报, 2020, 44(2): 215-220. DOI: CNKI:SUN:SDYX.0.2020-02-021.
|
|
HUANG X L, JIA X W, DING Y Q. Review on clinical application of Gegen Qinlian decoction[J]. J Shandong Univ Tradit Chin Med, 2020, 44(2): 215-220. DOI: CNKI:SUN:SDYX.0.2020-02-021.
|
|
| [9] |
孙洪平, 张会峰, 陈煜, 等. 葛根芩连汤调控FoxO1/MARCH1通路对小鼠胰岛素抵抗的改善作用[J]. 中成药, 2024, 46(5): 1662-1667. DOI: 10.3969/j.issn.1001-1528.2024.05.041.
|
|
SUN H P, ZHANG H F, CHEN Y, et al. Effect of Gegen Qinlian decoction on improving insulin resistance in mice by regulating FoxO1/MARCH1 pathway[J]. Chin Tradit Pat Med, 2024, 46(5): 1662-1667. DOI: 10.3969/j.issn.1001-1528.2024.05.041.
|
|
| [10] |
刘莲萱, 吴威, 庞琳琳, 等. 葛根芩连汤化学成分、药理作用及临床应用研究进展[J]. 中华中医药学刊, 2022, 40(3): 147-154. DOI: 10.13193/j.issn.1673-7717.2022.03.034.
|
|
LIU L X, WU W, PANG L L, et al. Research progress on chemical composition, pharmacological action and clinical application of Gegen Qinlian decoction[J]. Chin Arch Tradit Chin Med, 2022, 40(3): 147-154. DOI: 10.13193/j.issn.1673-7717.2022.03.034.
|
|
| [11] |
DILLMANN W H. Diabetic cardiomyopathy[J]. Circ Res, 2019, 124(8): 1160-1162. DOI: 10.1161/CIRCRESAHA.118.314665.
|
| [12] |
NAKAMURA K, MIYOSHI T, YOSHIDA M, et al. Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus[J]. Int J Mol Sci, 2022, 23(7): 3587. DOI: 10.3390/ijms23073587.
|
| [13] |
MARGULIES K B, HERNANDEZ A F, REDFIELD M M, et al. Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial[J]. JAMA, 2016, 316(5): 500-508. DOI: 10.1001/jama.2016.10260.
|
| [14] |
SEFEROVIĆ P M, COATS A J S, PONIKOWSKI P, et al. European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose-lowering drugs in patients with heart failure[J]. Eur J Heart Fail, 2020, 22(2): 196-213. DOI: 10.1002/ejhf.1673.
|
| [15] |
ZHOU M Z, ZHANG Y Y, SHI L, et al. Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions - A review[J]. Pharmacol Res, 2024, 206: 107282. DOI: 10.1016/j.phrs.2024.107282.
|
| [16] |
BUGGER H, ABEL E D. Molecular mechanisms of diabetic cardiomyopathy[J]. Diabetologia, 2014, 57(4): 660-671. DOI: 10. 1007/s00125-014-3171-6.
|
| [17] |
DING S J, XU S, MA Y, et al. Modulatory mechanisms of the NLRP3 inflammasomes in diabetes[J]. Biomolecules, 2019, 9(12): 850. DOI: 10.3390/biom9120850.
|
| [18] |
ZHENG X Q, WAN J, TAN G. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy[J]. Front Immunol, 2023, 14: 1151185. DOI: 10.3389/fimmu.2023.1151185.
|
| [19] |
CHEN Y, YE X Y, ESCAMES G, et al. The NLRP3 inflammasome: contributions to inflammation-related diseases[J]. Cell Mol Biol Lett, 2023, 28(1): 51. DOI: 10.1186/s11658-023-00462-9.
|
| [20] |
ZHANG X M, MIN X R, XIE H X, et al. Piperazine ferulate inhibits diabetic nephropathy by suppressing AGE/RAGE-mediated inflammatory signaling in rats and podocytes[J]. Front Pharmacol, 2024, 15: 1394369. DOI: 10.3389/fphar. 2024. 1394369.
|
| [1] | LI Yanping, HUANG Shan, YAO Jengyuan, SHI Yimin, SUI Huaxiu, HUANG Houtan, YU Yanping, MI Yan, LIN Tahui. Protective Effect and Mechanism of Artemitin on Ozone-Induced Pulmonary Inflammation in Mice [J]. Laboratory Animal and Comparative Medicine, 2026, 46(5): 640-649. |
| [2] | ZHANG Jiaoling, LIN Aping, XU Shiying, PAN Dequan, CAI Yijun. Optimization and Application of Mouse Embryo Transfer Technology [J]. Laboratory Animal and Comparative Medicine, 2026, 46(5): 750-758. |
| [3] | XU Haochen, LE Qingqing, HE Xiwen, CAI Bing, YANG Longhe. Evaluation of the Efficacy of an Eye-Protective Compound Formula on the Retina in a Mouse Model of Blue Light-Induced Damage [J]. Laboratory Animal and Comparative Medicine, 2026, 46(5): 650-659. |
| [4] | ZHONG Qiuming, QIAN Liping, CAI Yuanyuan, LIU Deqiang, LIN Wei, YU Chunying, XIE Jindong, WANG Xunli, WU Sheng, CHEN Biyin, HUANG Zhen. Comparative Analysis of Sex Differences Between Cyclophosphamide- and Paclitaxel-Induced Mouse Models of Chemotherapy-Induced Alopecia [J]. Laboratory Animal and Comparative Medicine, 2026, 46(5): 677-688. |
| [5] | WANG Juan, XU Jiahui, TIAN Yunyuan, ZHANG Mengmeng, LI Min, WANG Siwang, LI Yao. Comparison and Behavioral Observation of Two Female Mice Models of Ulcerative Colitis [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 332-343. |
| [6] | LI Longxue, WAN Chongfan, ZHANG Qi, LEI Ruting, WANG Xiaoyue, CHENG Leyan, LAI Qi, LIU Ronghua, LIU Xuan, XU Tielong. Molecular Mechanisms of Qingfei Paidu Decoction in the Prevention and Treatment of Acute Lung Injury in Mice Based on miRNA Sequencing [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 311-320. |
| [7] | AI Xiufeng, ZHANG Lizong, FANG Mingsun, LÜ Dongying, CHEN Chu, CAI Zhaowei, WANG Dejun. Analysis of Differences in the Intestinal Flora of Rats and Mice after Drinking Chlorinated Water Based on 16S rRNA Sequencing [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 437-445. |
| [8] | WU Xianwen, LIU Lili, CHEN Ye, XU Guoheng. Optimization of Cage-Changing Intervals and Wood Shavings Usage for Mice During the Growth Phase in Breeding Systems [J]. Laboratory Animal and Comparative Medicine, 2026, 46(2): 251-260. |
| [9] | RONG Wenshuang, NIU Yuanfei, LIU Meiting, YANG Mengyuan, CUI Shuang, MA Lina, FU Yao, WANG Lianmei, CAO Junling. Influence of Antigen Type on the Establishment of an Induced Sjögren Syndrome Mouse Model [J]. Laboratory Animal and Comparative Medicine, 2026, 46(2): 178-190. |
| [10] | XU Yingtao, WANG Mengmeng, LIN Ping, CHI Haitao, WANG Yi, BAI Ying. Exosomes Treat Ischemic Stroke by Regulation of Ferroptosis Through the NRF2/SLC7A11/GPX4 Pathway in Mice [J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 20-31. |
| [11] | LIU Zhiwei, YANG Ran, LIAN Hao, ZHANG Yu, JIN Lilun. Cartilage Protection and Anti-Inflammatory Effects of Fraxetin on Monosodium Iodoacetate-Induced Rat Model of Osteoarthritis [J]. Laboratory Animal and Comparative Medicine, 2025, 45(3): 259-268. |
| [12] | YIN Yulian, MA Lina, TU Siyuan, CHEN Ling, YE Meina, CHEN Hongfeng. Establishment and Evaluation of a Rat Model of Non-Puerperal Mastitis [J]. Laboratory Animal and Comparative Medicine, 2024, 44(6): 587-596. |
| [13] | Yisu ZHANG, Xinru LIU, Ruojie WU, Rui LIU, Hong OUYANG, Xiaohong LI. Establishment and Evaluation of Mouse Model of Pregnancy Pain-depression Comorbidity Induced by Chronic Unpredictable Stress, Complete Freund's Adjuvant and Formalin [J]. Laboratory Animal and Comparative Medicine, 2024, 44(3): 259-269. |
| [14] | Min LIANG, Yang GUO, Jinjin WANG, Mengyan ZHU, Jun CHI, Yanjuan CHEN, Chengji WANG, Zhilan YU, Ruling SHEN. Construction of Dmd Gene Mutant Mice and Phenotype Verification in Muscle and Immune Systems [J]. Laboratory Animal and Comparative Medicine, 2024, 44(1): 42-51. |
| [15] | Wenwen GUO, Ya ZHAO, Yinghua WANG, Ke LIU, Xu GE, Yanying ZHANG, Yongfeng WANG, Changhong SHI. Repairing Effects of Ginsenoside Rg1 on Traumatic Brain Injury in Mice [J]. Laboratory Animal and Comparative Medicine, 2023, 43(3): 243-252. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||